Solasia Pharma K.K.
4597ソレイジア・ファーマ株式会社
Latest half-year results
First half · fiscal year to 2026-12 · filed 2026-08-13For the first half of the fiscal year to 2026-12: Revenue ¥0 billion (-83.7% YoY), Profit before tax ¥-0.6 billion, Net income ¥-0.6 billion.
| This period | Year on year | |
|---|---|---|
| Revenue | ¥8m | -83.7% |
| Profit before tax | −¥579m | — |
| Net profit to owners | −¥579m | — |
From the securities report on EDINET, which states no forecast. History via /v1/companies/4597/earnings-releases.
Financials
IFRS · consolidated · fiscal year to 2025-12-31- Revenue
- ¥429m
- Net income
- −¥876m
- ROE
- —
- Equity ratio
- 81.7%
- Dividend / share
- —
- Employees
- 22
| Fiscal year | Revenue | Net income | Total assets | Net assets | ROE | EPS | Operating CF |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | ¥429m | −¥876m | ¥2,145m | ¥1,752m | — | ¥-3.69 | −¥847m |
| 2024-12-31 | ¥316m | −¥1,941m | ¥1,362m | ¥1,156m | — | ¥-9.77 | −¥1,033m |
| 2023-12-31 | ¥617m | −¥1,112m | ¥2,229m | ¥1,875m | — | ¥-6.62 | −¥359m |
| 2022-12-31 | ¥1,092m | −¥2,548m | ¥3,134m | ¥2,662m | — | ¥-16.77 | −¥2,074m |
| 2021-12-31 | ¥559m | −¥2,478m | ¥3,144m | ¥2,587m | — | ¥-19.04 | −¥2,473m |
Indicators
Computed by us from filings · fiscal year to 2025-12-31| Metric | Value | Percentile among listed companies |
|---|---|---|
| ROE, % | — | — |
| Ordinary margin | -2.042 | 0.9 |
| Equity ratio, % | 81.7 | 91.6 |
| Revenue growth | 0.3576 | 95.4 |
| Net income growth | 0.5487 | 76.8 |
| Operating cash flow / assets | -0.3949 | 1 |
Results wording balance: -1.00. Proprietary text method; it describes the wording only and does not interpret context.
Via /v1/companies/4597/indicators. Descriptive figures, not a rating and not investment advice.
From other filings
As the company states themSegments, votes and tender offers
Stated in EDINET filings/v1/companies/4597/votingOwnership changes
All companies →- 2026-01-16
Macquarie Bank Limited cut holdings in Solasia Pharma K.K. (4597) to 4.45% from 6.12%, below the 5% threshold.
- 2026-01-08
Macquarie Bank Limited reduced holdings in Solasia Pharma K.K. (4597) to 6.12% from 7.38%.
- 2025-11-28
Macquarie Bank Limited reduced holdings in Solasia Pharma K.K. (4597) to 7.38% from 8.49%.
- 2025-08-29
Macquarie Bank Limited reduced holdings in Solasia Pharma K.K. (4597) to 8.49% from 9.73%.
- 2025-08-06
Macquarie Bank Limited reduced holdings in Solasia Pharma K.K. (4597) to 9.73% from 11.62%.
- 2025-08-06
Holdings of Macquarie Bank Limited in Solasia Pharma K.K. (4597) moved below 10% (11.62% -> 9.73%).
- 2025-07-23
Macquarie Bank Limited reduced holdings in Solasia Pharma K.K. (4597) to 11.62% from 12.64%.
- 2025-07-11
Macquarie Bank Limited reduced holdings in Solasia Pharma K.K. (4597) to 12.64% from 13.73%.
- 2025-07-10
Macquarie Bank Limited reduced holdings in Solasia Pharma K.K. (4597) to 13.73% from 15.12%.
- 2025-07-04
Macquarie Bank Limited raised holdings in Solasia Pharma K.K. (4597) to 15.12% from 13.83%.
Trades by 5% holders
From the 60-day trade tables in 5% reports| Holder | Period | Net shares | Net % of shares | Avg. filed price | Range |
|---|---|---|---|---|---|
| Macquarie Bank Limited | 2022-02-14 – 2025-07-31 | +116,320,400 | +50.74pt | ¥39.93 | ¥23–104 |
| マッコーリー バンク リミテッド | 2024-06-26 – 2024-07-04 | +65,000 | +0.02pt | ¥27 | ¥27–27 |
| NOMURA INTERNATIONAL PLC | 2022-09-20 – 2022-11-25 | +4,283,900 | +2.62pt | ¥53.68 | ¥48–57 |
| 野村證券株式会社 | 2022-09-20 – 2022-11-25 | +7,930,200 | +4.71pt | ¥54.84 | ¥48–55 |
| 伊藤忠商事株式会社 | 2022-09-07 – 2022-11-15 | -22,670,000 | −13.48pt | ¥57 | ¥57–57 |
| 日本化薬株式会社 | 2022-07-14 – 2022-07-14 | +12,000,000 | +7.77pt | ¥85 | ¥85–85 |
Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4597/trades.
5% filings
Large shareholding reports on 4597| Filed | Filer | Stake | Change | Stated purpose |
|---|---|---|---|---|
| 2026-01-16 | Macquarie Bank Limited | 4.45% | −1.67pt | pure investment |
| 2026-01-08 | Macquarie Bank Limited | 6.12% | −1.26pt | pure investment |
| 2025-11-28 | Macquarie Bank Limited | 7.38% | −1.11pt | pure investment |
| 2025-08-29 | Macquarie Bank Limited | 8.49% | −1.24pt | pure investment |
| 2025-08-06 | Macquarie Bank Limited | 9.73% | −1.89pt | pure investment |
| 2025-07-23 | Macquarie Bank Limited | 11.62% | −1.02pt | pure investment |
| 2025-07-11 | Macquarie Bank Limited | 12.64% | −1.09pt | pure investment |
| 2025-07-10 | Macquarie Bank Limited | 13.73% | −1.39pt | pure investment |
| 2025-07-04 | Macquarie Bank Limited | 15.12% | +1.29pt | pure investment |
| 2025-07-03 | Macquarie Bank Limited | 13.83% | −2.17pt | pure investment |
Cross-shareholdings
From the annual report's status of shareholdings- Listed strategic holdings
- 1 issues
- Book value
- ¥77m
- Sold in the year
- — — issues
- Bought in the year
- ¥77m 1 issues
- Mutual, both reports
- 0
- Held by listed cos.
- 1
| Holds | Book value | Shares vs. prior year | Mutual |
|---|---|---|---|
| Isofol Medical AB | ¥77m | — | no |
Held by: NIPPON KAYAKU CO.,LTD. 4272
Purposes, all holdings and mutual flags via /v1/companies/4597/cross-holdings. Share changes include stock splits.
Major shareholders
As of fiscal year end 2025-12-31| Shareholder | Shares | Ratio |
|---|---|---|
| 日本化薬株式会社 | 12,000,000 | 4.55% |
| マルホ株式会社 | 11,324,000 | 4.29% |
| MACQUARIE BANK LIMITED DBU AC | 8,451,200 | 3.20% |
| 楽天証券株式会社共有口 | 3,075,300 | 1.16% |
| individual holder | 1,584,545 | 0.60% |
| individual holder | 1,584,200 | 0.60% |
| 日本証券金融株式会社 | 1,192,000 | 0.45% |
| MSIP CLIENT SECURITIES | 1,062,522 | 0.40% |
| individual holder | 1,004,200 | 0.38% |
| BNY GCM CLIENT ACCOUNT JPRD AC ISG（FE-AC） | 1,004,000 | 0.38% |
U.S. funds holding 4597
SEC Form N-PORT, reports to 2026-07-311 U.S. funds held 844,100 shares worth $0.1m.
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares International Small-Cap Equity Factor ETF iShares Trust | 844,100 | $0.1m | 0.022% | 2026-07-31 |
Up to 25 funds per stock via the API.
Get this as JSON
GET /v1/companies/4597
GET /v1/companies/4597/financials
GET /v1/companies/4597/details
GET /v1/companies/4597/segments
GET /v1/companies/4597/voting
GET /v1/companies/4597/tender-offers
GET /v1/companies/4597/indicators
GET /v1/companies/4597/earnings-releases
GET /v1/events?ticker=4597
GET /v1/companies/4597/trades
GET /v1/companies/4597/cross-holdings
GET /v1/companies/4597/brief